Completed
Panitumumab in Combination With Irinotecan Chemotherapy as 2nd-line Therapy in Subjects With mCRC
NCT00475293
- Conditions
- Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +9 more
- Locations
-
- Spanish Cooperative Group for Gastrointestinal Tumour Therapy Madrid, Spain